1. Home
  2. TWST vs NVG Comparison

TWST vs NVG Comparison

Compare TWST & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • NVG
  • Stock Information
  • Founded
  • TWST 2013
  • NVG 1999
  • Country
  • TWST United States
  • NVG United States
  • Employees
  • TWST N/A
  • NVG N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • NVG Investment Managers
  • Sector
  • TWST Health Care
  • NVG Finance
  • Exchange
  • TWST Nasdaq
  • NVG Nasdaq
  • Market Cap
  • TWST 2.7B
  • NVG 2.7B
  • IPO Year
  • TWST 2018
  • NVG N/A
  • Fundamental
  • Price
  • TWST $42.23
  • NVG $12.88
  • Analyst Decision
  • TWST Buy
  • NVG
  • Analyst Count
  • TWST 8
  • NVG 0
  • Target Price
  • TWST $52.25
  • NVG N/A
  • AVG Volume (30 Days)
  • TWST 908.0K
  • NVG 568.8K
  • Earning Date
  • TWST 11-18-2024
  • NVG 01-01-0001
  • Dividend Yield
  • TWST N/A
  • NVG 4.65%
  • EPS Growth
  • TWST N/A
  • NVG N/A
  • EPS
  • TWST N/A
  • NVG N/A
  • Revenue
  • TWST $312,974,000.00
  • NVG N/A
  • Revenue This Year
  • TWST $21.05
  • NVG N/A
  • Revenue Next Year
  • TWST $20.16
  • NVG N/A
  • P/E Ratio
  • TWST N/A
  • NVG N/A
  • Revenue Growth
  • TWST 27.69
  • NVG N/A
  • 52 Week Low
  • TWST $23.07
  • NVG $9.68
  • 52 Week High
  • TWST $60.90
  • NVG $12.21
  • Technical
  • Relative Strength Index (RSI)
  • TWST 48.97
  • NVG 50.58
  • Support Level
  • TWST $39.81
  • NVG $12.72
  • Resistance Level
  • TWST $42.99
  • NVG $12.93
  • Average True Range (ATR)
  • TWST 2.59
  • NVG 0.13
  • MACD
  • TWST -0.10
  • NVG 0.03
  • Stochastic Oscillator
  • TWST 45.32
  • NVG 71.01

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

About NVG Nuveen AMT-Free Municipal Credit Income Fund

Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax. The Fund invests predominantly in investment grade municipal bonds that are exempt from regular federal income taxes.

Share on Social Networks: